What Analysts Are Saying About Avantor Stock

In the latest quarter, 6 analysts provided ratings for Avantor (NYSE:AVTR), showcasing a mix of bullish and bearish perspectives.

The table below offers a condensed view of their recent ratings, showcasing the changing sentiments over the past 30 days and comparing them to the preceding months.

	Bullish	Somewhat Bullish	Indifferent	Somewhat Bearish	Bearish
Total Ratings	0	1	4	1	0
Last 30D	0	1	0	0	0
1M Ago	0	0	2	0	0
2M Ago	0	0	2	1	0
3M Ago	0	0	0	0	0

Analysts have set 12-month price targets for Avantor, revealing an average target of $11.17, a high estimate of $14.00, and a low estimate of $9.00. A negative shift in sentiment is evident as analysts have decreased the average price target by 17.26%.

Deciphering Analyst Ratings: An In-Depth Analysis

The standing of Avantor among financial experts becomes clear with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.

Analyst	Analyst Firm	Action Taken	Rating	Current Price Target	Prior Price Target
Brandon Couillard	Wells Fargo	Lowers	Overweight	$14.00	$16.00
Patrick Donnelly	Citigroup	Lowers	Neutral	$11.00	$13.00
Luke Sergott	Barclays	Lowers	Equal-Weight	$9.00	$12.00
Dan Brennan	TD Cowen	Lowers	Hold	$12.00	$14.00
Vijay Kumar	Evercore ISI Group	Lowers	In-Line	$12.00	$14.00
Tycho Peterson	Jefferies	Lowers	Underperform	$9.00	$12.00

Key Insights:

• Action Taken: Analysts respond to changes in market conditions and company performance, frequently updating their recommendations. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Avantor. This information offers a snapshot of how analysts perceive the current state of the company.
• Rating: Analyzing trends, analysts offer qualitative evaluations, ranging from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Avantor compared to the broader market.
• Price Targets: Understanding forecasts, analysts offer estimates for Avantor's future value. Examining the current and prior targets provides insight into analysts' changing expectations.

Considering these analyst evaluations in conjunction with other financial indicators can offer a comprehensive understanding of Avantor's market position. Stay informed and make well-informed decisions with our Ratings Table.

Stay up to date on Avantor analyst ratings.

Get to Know Avantor Better

Avantor Inc provider of products and services to customers in the biopharma, healthcare, education & government, and advanced technologies & applied materials industries. The company has three geographic segments: the Americas, Europe, and AMEA. The company's product group consists of Equipment & instrumentation, Services & specialty procurement, Proprietary materials & consumables, and Third-party materials & consumables. Materials & consumables include high-purity chemicals and reagents, lab products and supplies, specialized formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, and education and microbiology and clinical trial kits, peristaltic pumps and fluid handling tips.

Avantor: A Financial Overview

Market Capitalization Analysis: Below industry benchmarks, the company's market capitalization reflects a smaller scale relative to peers. This could be attributed to factors such as growth expectations or operational capacity.

Revenue Challenges: Avantor's revenue growth over 3M faced difficulties. As of 30 September, 2025, the company experienced a decline of approximately -5.28%. This indicates a decrease in top-line earnings. When compared to others in the Health Care sector, the company faces challenges, achieving a growth rate lower than the average among peers.

Net Margin: Avantor's net margin is below industry averages, indicating potential challenges in maintaining strong profitability. With a net margin of -43.84%, the company may face hurdles in effective cost management.

Return on Equity (ROE): The company's ROE is below industry benchmarks, signaling potential difficulties in efficiently using equity capital. With an ROE of -12.01%, the company may need to address challenges in generating satisfactory returns for shareholders.

Return on Assets (ROA): Avantor's ROA lags behind industry averages, suggesting challenges in maximizing returns from its assets. With an ROA of -5.82%, the company may face hurdles in achieving optimal financial performance.

Debt Management: Avantor's debt-to-equity ratio is below the industry average. With a ratio of 0.69, the company relies less on debt financing, maintaining a healthier balance between debt and equity, which can be viewed positively by investors.

Analyst Ratings: Simplified

Ratings come from analysts, or specialists within banking and financial systems that report for specific stocks or defined sectors (typically once per quarter for each stock). Analysts usually derive their information from company conference calls and meetings, financial statements, and conversations with important insiders to reach their decisions.

Some analysts also offer predictions for helpful metrics such as earnings, revenue, and growth estimates to provide further guidance as to what to do with certain tickers. It is important to keep in mind that while stock and sector analysts are specialists, they are also human and can only forecast their beliefs to traders.

This article was generated by Benzinga's automated content engine and reviewed by an editor.